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Organotypic cerebellar slices represent a suitable model for characterizing and
manipulating prion replication in complex cell environments. Organotypic slices
recapitulate prion pathology and are amenable to drug testing in the absence of a
blood-brain-barrier. So far, the cellular and subcellular distribution of disease-specific
prion protein in organotypic slices is unclear. Here we report the simultaneous detection
of disease-specific prion protein and central nervous system markers in wild-type mouse
cerebellar slices infected with mouse-adapted prion strain 22L. The disease-specific
prion protein distribution profile in slices closely resembles that in vivo, demonstrating
granular spot like deposition predominately in the molecular and Purkinje cell layers.
Double immunostaining identified abnormal prion protein in the neuropil and associated
with neurons, astrocytes and microglia, but absence in Purkinje cells. The established
protocol for the simultaneous immunohistochemical detection of disease-specific prion
protein and cellular markers enables detailed analysis of prion replication and drug
efficacy in an ex vivo model of the central nervous system.
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INTRODUCTION
Transmissible spongiform encephalopathies or prion diseases are devastating neurologic
diseases of mammals associated with spongiform degeneration and gliosis in the central
nervous system (Prusiner, 1991). Prion diseases are caused by unconventional pathogens
composed predominately or exclusively of misfolded cellular prion protein (Prusiner,
1982). They replicate by recruiting and converting cellular prion protein (PrPC) into
disease-associated higher order structures. Prions exist as stable strains that propagate
in specific brain areas and even subpopulations of cells in genetically defined rodents
Abbreviations: DS-500, Dextran sulfate 500; GFAP, Glial fibrillary acidic protein; p.i., post infection; PrPC, Prion Protein;
PrPSc , Proteinase K resistant PrP; PrPd, Disease-associated PrP, detected by immunofluorescence following guanidine
hydrochloride treatment; PK, Proteinase K.
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(Dickinson and Meikle, 1971; Bruce et al., 1991; Hecker et al.,
1992; Bruce, 2003). It is unknown how prions target specific brain
regions and lead to distinct disease pathologies (Kimberlin and
Walker, 1986).
Rodent models have uncovered essential details on prion
strain characteristics. However, the usually long incubation
times make bioassays time-consuming and expensive. The
recent development of the prion organotypic slice culture assay
opens new avenues for studying molecular mechanism of prion
propagation ex vivo (Falsig et al., 2008). Organotypic slice
cultures can be maintained for several months while largely
retaining their in vivo cytoarchitecture. Importantly, organotypic
slice cultures can be easily manipulated chemically (Falsig
et al., 2008, 2012) or genetically (Hofmann et al., 2013) and
thus represent suitable models to study host cell responses
in complex tissue environments. Cerebellar slices efficiently
propagate prions and exhibit characteristic features of prion
disease such as astro- and microgliosis, loss of dendritic spines,
and spongiform changes (Falsig et al., 2008, 2012; Campeau
et al., 2013). However, it is unclear if the PrP deposition
pattern in infected slices resembles that of in vivo infected
cerebella.
As the precise molecular nature of the infectious agent
is unknown, prions can only be operationally defined. The
term PrPSc often denotes partially proteinase K-resistant PrP.
The term PrPd has been used to define disease-associated PrP
detected by immunohistochemical analysis of formalin-fixed
paraffin embedded sections following antigen retrieval (Jeffrey
et al., 2011). Both PrPSc and PrPd serve as surrogate markers
for disease. The use of horseradish peroxidase/chromogenic
substrates in immunohistochemistry hasmajor limitations in that
detection of multiple antigens in the same section is difficult.
Immunostaining using fluorophore-conjugated antibodies has
recently been used by the prion community for achieving a higher
level of detail on subcellular distribution and simultaneous
detection of several antigens within one specimen. Some recent
studies successfully employed protein denaturation protocols for
the simultaneous detection of disease-associated PrP and cellular
markers (Ayers et al., 2011). However, no such staining has been
reported for organotypic slice cultures. Instead, histoblot and
western blot analysis have been used to study tissue distribution
and relative levels of PrPSc produced upon infection (Falsig
et al., 2012). Detailed information as to whether the cellular and
subcellular distribution of disease-associated PrPd mimics the
in vivo situation is missing (Falsig et al., 2008, 2012; Campeau
et al., 2013).
We developed a novel staining protocol that combines
PrPd denaturation, multicolor immunofluorescence staining,
and confocal microscopy of whole mount organotypic
cerebellar slices that allows for detailed analysis of cellular
and subcellular distribution of abnormal PrP deposits. Here
we show that organotypic brain slice cultures recapitulate
the neuropathological hallmarks of prion disease and exhibit
a PrPd deposition pattern comparable to in vivo infected
cerebella. The possibility of high resolution microscopy of prion
deposits together with the ease of chemical manipulation make
organotypic brain slice cultures a highly suitable model for
in-depth neuropathological analysis of prion disease progression
that limits invasive procedures on living animals.
MATERIALS AND METHODS
Ethics Statement and Mice
Animal care and experimental procedures were conducted
according to the institutional animal care committee guidelines
and German animal protection laws and were approved by the
Landesamt für Natur, Umwelt, und Verbraucherschutz NRW.
Female C57BL/6JRj mice with pups, at the age of P7, were
ordered from Janvier (St. Berthevin Cedex, France) and were
housed at a 12:12 light: dark cycle with food and water available
ad libidum.
Chemicals
If not otherwise specified, chemicals and reagents were purchased
from Sigma (Steinheim, Germany) or Roth (Karlsruhe,
Germany). Pefabloc was obtained from Roche (Mannheim,
Germany) and staurosporine was purchased from Enzo (Lausen,
Switzerland). Ultrapure low-melting-point agarose, slice
culture media, supplements and heat inactivated horse serum
were obtained from Invitrogen (Darmstadt, Germany). The
bicinchoninic acid assay kit was purchased from Pierce (Thermo
Scientific, Rockford, USA). The ECL plus chemiluminescence
kit was purchased from GE Healthcare (Buckinghamshire,
UK). Monoclonal anti-PrP antibody 4H11 has been described
previously (Ertmer et al., 2004). The antibody is directed against
the globular domain of the protein. Anti-actin antibody was
obtained from MP Biomedicals (Eschwede, Germany) and
rabbit polyclonal anti-β-3-tubulin antibody was purchased
from Covance HISS Diagnostics (Freiburg, Germany). Anti-
calbindin D-28K antibody was purchased from Swant (Marly,
Switzerland), anti-GFAP antibody was obtained from Dako
Cytomation (Hamburg, Germany), anti-iba-1 antibody was
purchased from Wako Pure Chemicals Industries (Osaka,
Japan), and anti-lamp-1 antibody was obtained from Santa
Cruz Biotechnology (Santa Cruz, USA). Fluorescein-conjugated
secondary antibodies were purchased from Dianova (Hamburg,
Germany) or from Life Technologies (Darmstadt, Germany).
Preparation of Organotypic Cerebellar
Slices and Prion Infection
Organotypic cerebellar slices were prepared from postnatal day
9–13 (P9–13) old pups of C57BL/6JRj mice according to a
previously published protocol (Falsig et al., 2008). Cerebella
were extracted and imbedded in 2% liquid low-melting-point
agarose. 350µm thick sections of the medial cerebellum (vermis)
were cut with a vibratome (VT1200S, Leica Biosystems, Wetzlar,
Germany) and were collected in a reservoir filled with ice
cold Gey’s balanced salt solution supplemented with 1mM
kynurenic acid and D-(+)-glucose. Agarose and meninges
were removed. Prion infection studies were conducted under
biosafety containment level two. Mouse-adapted scrapie strain
22L propagated in C57BL/6 mice was used for infection. 10%
brain homogenates of healthy control mice and terminally sick
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mice were prepared according to a standardized protocol in
Opti-MEM medium using a dounce homogenizer. Cell debris
was pelleted by centrifugation at 872 g, 4◦C, for 5min and
the supernatant was stored at –80◦C. Up to 10 slices were
exposed to 20mg/ml brain homogenate. Slices were incubated
as free-floating sections at 4◦C for 1 h under permanent shaking.
After three washing steps with cold Gey’s balanced salt solution
supplemented with 1mM kynurenic acid and D-(+)-glucose, 2–
6 slices were placed on membrane inserts (Millicell-CM inserts,
0.4µm, 30mm, Millipore, Carrigtwohill, Co. Cork, Ireland) in
6 well plates containing slice culture medium (100ml 2 ×
MEM, 100ml BME, 100ml horse serum, 4ml GlutaMAX-I, 4ml
penicillin/streptomycin, 5.5ml D-(+)-glucose solution (45%),
86.5ml H2Obidest, pH 7.2–7.4). Slices were cultured up to 12
weeks at 37◦C, 5% CO2 and 95% humidity. Every second day,
95% of the medium was replaced by fresh slice culture medium.
Dextran Sulfate Treatment
For the treatment with dextran sulfate (DS-500) before and
during the prion infection, cerebellar slices were pretreated
for 1 h and were then infected with 22L brain homogenate
in the presence of 1–10µg/ml DS-500. After three rinsing
steps, cerebellar slices were cultivated with slice culture
medium containing 1–10µg/ml DS-500 during the first week of
cultivation. Cerebellar slices were also treated at later time points
during prion infection, starting the third week of cultivation until
analysis.
Propidium Iodide Staining
Tissue viability was assessed by detection of propidium iodide
incorporation into dead cells of cerebellar slices. Cerebellar slices
were incubated with 10µg/ml propidium iodide at 37◦C for
2 h. After rinsing the slices with Gey’s balanced salt solution
supplemented with 1mM kynurenic acid and D-(+)-glucose,
the propidium iodide incorporation was detected by using an
inverse fluorescence microscope (Axio observer Z1, Zeiss, Jena,
Germany). Slices treated with 5µM staurosporine were used
as positive controls. The exposure time to visually detect the
propidium iodide staining was adjusted to the exposure time of
slices treated with staurosporine. For comparison, all images were
taken using the same microscopic settings.
Immunofluorescence Detection of PrPd by
Epifluorescence and Confocal Microscopy
Whole mount cerebellar slices were rinsed with PBS, fixed with
4% PFA at RT for 2 h, and permeabilized with 0.5% Triton X-
100 at 4◦C for 18 h. PrP was denatured with 6M guanidine
hydrochloride or >98% formic acid at RT for 3 h for demasking
epitopes in PrPd. After rinsing, cerebellar slices were blocked
with 5% BSA up to 3 days and slices were incubated with
the primary antibodies diluted in 5% BSA at 4◦C for 3 days,
followed by extensive washing and incubation with the suitable
fluorophore-conjugated secondary antibodies diluted in 5% BSA
at 4◦C for 3 days. Cellular nuclei were stained with Hoechst
(Molecular Probes, Eugene, Oregon, USA) using a 1:10,000
dilution in PBS at RT. The analysis of the samples was conducted
with an inverse epifluorescence microscope (Axio observer Z1,
Zeiss, Jena, Germany) or with an automated epifluorescence
microscope (Axio scan Z1, Zeiss, Jena, Germany) for an overview
using the tile scanning function. For high-resolution images a
LSM 700 laser scanning microscope (Zeiss, Jena, Germany) was
used. Images were taken in a focal plane∼8µm below the top of
the slice. To quantify differences between fluorophore intensities,
channel settings were kept constant within one experiment or
between various experiments. Mock exposed slices were included
in every experiment and were used as controls for residual
background staining of PrPC.
Western Blot Analysis
Two slices were pooled and lysed in lysis buffer (0.5% deoxycholic
acid sodium salt, 0.5% Nonidet P40 substitute). Lysis of the
tissue was performed by three freeze and thaw cycles, including
dissociation of the tissue using a pipette and sonication (Sonoplus
HD3200, Bandelin Sonorex Technik, Berlin, Germany). If
needed, a short centrifugation step was included. Precipitates
were cleared by a low speed centrifugation (1153 g, 4◦C, 3min).
The protein concentration of the lysates was determined using
the bicinchoninic acid assay kit (Thermo Scientific, Rockford,
USA). For the specific detection of PrPSc, 20µg protein was
digested with 62.5µg/ml proteinase K at 37◦C for 30min.
Proteolysis was terminated by adding Pefabloc SC and NuPAGE
LDS sample buffer (Invitrogen, Darmstadt, Germany) and by
boiling the sample at 95◦C for 5min. 5–10µg protein was used
to assay for actin as a loading control. Proteins were separated
on NuPAGE Novex 4–12% Bis-Tris Midi gels (Invitrogen,
Darmstadt, Germany) and were detected by western blot
using primary antibodies and horseradish peroxidase-conjugated
secondary antibodies.
Statistics
Data sets were analyzed with the One-way analysis of variances
(ANOVA). To evaluate statistically significant differences
between control and sample, Dunnett’s or Tukey’s multiple
comparisons post-hoc test or unpaired two-tailed t-test were
used. P-values less than 0.05 were considered significant
(∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). Error
bars represent standard deviation (SD) and the sample size (n)
was at least three or more.
RESULTS
Propagation of Mouse-adapted Prion
Strain 22L in C57BL/6JRj Cerebellar Slices
We chose wildtype C57BL/6JRj mice for preparation of cerebellar
slices to monitor prion infection under normal cerebellar PrPC
expression conditions. Sagittal 350µm sections cut through the
cerebellar vermis of pups at postnatal day 9–13 (P9–13) were
exposed to normal brain homogenate or infected with scrapie
brain homogenate and slices were subsequently cultured for a
period of up to 11.5 weeks (Figure 1A). Western blot analysis of
proteinase K (PK) resistant PrP (PrPSc) at different time points
post infection (p.i.) revealed a dramatic increase of PrPSc over
time, demonstrating an efficient propagation of prion strain 22L.
No PrPSc was detected in Mock exposed slices (Figure 1B). Prion
infection did not significantly decrease cell viability compared
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FIGURE 1 | Viability of sagittal cerebellar slices infected with 22L prions. (A) Experimental setup. Organotypic slices of cerebella from 9 to 13 days old
C57BL/6JRj mice were prepared and exposed to 20mg/ml 22L brain homogenate or Mock brain homogenate. Slices were cultured on membrane inserts for up to
11.5 weeks. (B) Cerebellar slices exposed to Mock brain homogenate or infected with 22L prions were cultured for up to 5 weeks and slice lysates were subjected to
proteinase K (PK) treatment. PrPSc was detected by western blot using mAb 4H11. (C) Slices were cultured for 10.5 weeks and subsequently stained for dead cells
using propidium iodide (PI). Slices treated with 5µM staurosporine served as positive controls. Samples were analyzed by epifluorescence microscopy using the tile
scanning function with identical imaging settings. Scale bar: 500µm. Statistical analysis was performed using One-way ANOVA with Tukey’s multiple comparisons test.
Asterisks indicate significant changes (n = 3; **p < 0.01; ns, not significant). WB, western blot; IF, immunofluorescence; p.i., post infection; Stauro., staurosporine.
to Mock exposed slices at 10.5 weeks post exposure to prions
(Figure 1C). In conclusion, prion infected and Mock exposed
slices are viable over a cultivation period of more than 10 weeks.
Detection of Disease-associated PrPd
Following Antigen Denaturation
Propagation of prions in organotypic slices has previously been
assessed by western blot or histoblot techniques (Falsig et al.,
2012). These techniques provide only limited information on the
cellular distribution of disease-associated prion protein in the
slice. We developed an epitope denaturation protocol to visualize
the cellular localization of disease-associated PrP and cellular
markers in organotypic brain slices.We use the term PrPd to refer
to disease-associated PrP detected by fluorophore-conjugated
antibodies following antigen denaturation. PrPd detected by
immunohistochemistry likely comprises both proteinase K
sensitive and resistant forms (Jeffrey et al., 2011). We chose
slices 5.5 weeks post exposure, a time point at which prominent
PrPSc accumulation was detected by western blot analysis
(Figure 1B). Several protocols for antigen denaturation were
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FIGURE 2 | Immunofluorescence detection of PrPd in cerebellar slices treated with guanidine hydrochloride 5.5 weeks post exposure to 22L prions.
Cerebellar slices were exposed to Mock brain homogenate or infected with 22L prions and cultured for (A) 2.5 or (B) 5.5 weeks. Slices were treated with guanidine
hydrochloride for the specific detection of PrPd with mAb 4H11 (green). “PrP” and “β-3-tubulin” in the top left corner of the images denote the antigens detected by
the specific antibodies. Slight background staining for PrP was observed in Mock exposed slices by epifluorescence microscopy of whole slices. Neurons were
stained with pAb against β-3-tubulin (red), nuclei were counterstained with Hoechst. All samples were analyzed by epifluorescence microscopy using the tile scanning
function with identical imaging settings for each sample group. Scale bar: 500µm.
compared using prion infected and Mock exposed slices,
varying denaturation methods and incubation times (Figure 2,
Supplementary Figure 1). Whole mount slices were stained
without reslicing. Continuous culture led to thinning of the
slices to approximately 30µm. Epifluorescence microscopy using
tile scanning function and identical imaging settings for each
sample group revealed the stereotypical vermis foliation pattern
consisting of 10 lobules. The tissue structure with granular layer,
Purkinje cell layer, and molecular layer was grossly preserved.
No difference in PrP distribution was observed between 5.5
week old Mock exposed and 22L infected slices when antigen
denaturation was omitted (Supplementary Figure 1A). Antigen
denaturation with formic acid for 3 h slightly enhanced PrP
detection in prion infected slices, but relatively high PrP
signals were apparent also in Mock exposed slices. Hoechst
staining appeared slightly blurred by formic acid treatment
(Supplementary Figure 1B). Varying the incubation times for the
formic acid did not improve the staining results for Hoechst
or PrPd (data not shown). Best results were obtained upon
antigen denaturation by 6M guanidine hydrochloride (Figure 2;
Taraboulos et al., 1990). Control experiments using only
fluorophor-conjugated secondary antibodies or combinations
of primary antibodies with three species-specific secondary
antibodies did not reveal any background staining or cross-
reactivity of antibodies (data not shown). Consistent with
our western blot data (Figure 1B), no distinct staining of
PrPd was detected in 22L infected slices compared to Mock
exposed slices 2.5 weeks p.i. (Figure 2A). At 5.5 weeks p.i., a
strong increase in PrPd immunoreactivity was observed over
a slight PrP background in Mock exposed slices (Figure 2B).
Guanidine hydrochloride treatment had no discernible effect on
the immunoreactivity of β-3-tubulin or nuclear staining using
Hoechst.
Localization of PrPd in Molecular and
Purkinje Cell Layers
PrPd deposition patterns were assessed by confocal microscopy
in slices 5.5 weeks post exposure to brain homogenates
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FIGURE 3 | PrPd levels in molecular and Purkinje cell layers. (A,B) Cerebellar slices exposed to Mock brain homogenate or infected with 22L prions and
cultured for 5.5 weeks were stained for PrPd (green) following antigen denaturation. PAb against β-3-tubulin (red) was used to label neurons, nuclei were
counterstained with Hoechst. Samples were analyzed by epifluorescence microscopy using the tile scanning function (left panels, scale bar: 500µm). Insets of the
granular layer including the white matter (upper panels) and the molecular layer including the Purkinje cell layer (PC) (lower panels) were analyzed by confocal
microscopy (right panels, scale bar: 20µm). (C) Epifluorescence images of cerebellar slices 9 weeks p.i. stained for PrPd (green) following antigen denaturation. Scale
bar: 500µm. (D) Cerebellar folia I-X (from anterior to posterior) were manually demarcated and the PrP intensity per folium was quantified relative to the PrP intensity
of the whole slice set to 100% (total). Bars represent mean values ±SD of 14 slices. Statistical analysis was performed using One-way ANOVA with Dunnett’s multiple
comparisons test. Asterisks indicate significant changes (****p < 0.0001; **p < 0.01; *p < 0.05; ns, not significant).
(Figures 3A,B). Only moderate PrPd staining was detected in the
granular layer (upper panels) and the white matter of cerebellar
slices infected with 22L prions. By contrast, widespread PrPd
deposition was observed in the neuropil of the molecular and
Purkinje cell layers (Figure 3B, lower panels). Purkinje cell layers
(Purkinje cells are marked with arrowheads) of both prion
infected and Mock exposed slices were arranged as a multilayer,
consistent with the reported broadening of cell layers ex vivo
(Falsig et al., 2008). Amyloid plaques were absent from prion or
Mock infected slices. Consistent with in vivo studies, Purkinje
cells did not exhibit PrPd staining (Moore et al., 2008; Sarasa et al.,
2012).
The mammalian cerebellum is subdivided into several lobes
separated by fissures. Most prominent fissures compartmentalize
the cerebellum into anterior lobe (anterior folia I–V), middle
lobe (folia VI–VII), and caudal lobe (folia VIII–X) (Herrup
and Kuemerle, 1997). Epifluorescence analysis revealed that folia
differed in PrPd deposition patterns, with folia VI-X generally
exhibiting stronger stainings compared to folia I-V. Quantitative
analysis of PrP fluorescence intensities of whole slices 9 weeks
post exposure (Figure 3C) confirmed signifcantly higher PrPd
intensities in folia VI+ VII, VIII, IX, and X (Figure 3D).
Neuropathological Changes in 22L Infected
Cerebellar Slices
Consecutive sections of 22L infected and Mock exposed slices
9 weeks p.i. were imaged for vacuole formation (Figure 4).
Consistent with in vivo vacuolization patterns (Kim et al.,
1990a), spongiform changes were also apparent in the gray
matter, particularly in molecular and Purkinje cell layers of
22L infected organotypic cerebellar slices. No vacuolation was
observed in Mock exposed slices imaged using the same settings
(data not shown). Confocal immunofluorescence analysis of
22L infected slices 9 weeks p.i. (∼10µm from the top of
the slice) demonstrated a substantial reduction in β-3-tubulin
immunoreactivity compared to Mock exposed slices, indicative
of neuronal loss (Figure 5A). Numbers of Purkinje cells appeared
reduced upon prion infection (Figure 5B). Purkinje cells in
Mock exposed slices exhibited a well-defined arborization
penetrating into the molecular layer of the cerebellum. By
contrast, arborizations of Purkinje cells in 22L infected slices
appeared degenerated. An increase in GFAP immunoreactivity
was observed in prion infected compared to Mock exposed
slices (Figure 5C). Concomitantly, the number of iba-1 positive
microglia increased in 22L infected slices (Figure 5D). In
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FIGURE 4 | Spongiform changes in cerebellar slices 9 weeks post exposure to 22L prions. Following antigen denaturation, PrPd was detected with mAb
4H11 (green), Purkinje cells were detected using anti-calbindin mAb (red). Nuclei were counterstained with Hoechst. Cerebellar slices exposed to Mock brain
homogenate served as controls (data not shown). Samples were analyzed by confocal microscopy using the tile scanning and z-stack functions with identical imaging
settings. Consecutive sections through the slice were imaged every 0.9µm from the bottom to the top. Shown are nine consecutive sections from the z-layer of the
slices. Arrows mark vacuolations. Scale bar: 50µm.
summary, characteristic hallmarks of prion diseases including
spongiform changes, Purkinje cell degeneration, astro- and
microgliosis were reproduced in 22L infected organotypic
cerebellar slices from C57BL/6JRj mice.
PrPd Localizes in the Neuropil Associated
with Astrocytes and Microglia
To identify the cellular localization of PrPd, double labeling
of PrPd with neurons (β-3-tubulin), Purkinje cells (calbindin),
astrocytes (GFAP), and microglia (iba-1) was performed.
Potential subcellular deposition of PrPd within lysosomes was
assessed using mAb targeting lamp-1. The molecular and
Purkinje cell layers exhibited intense spot-like to fibrillar PrPd
deposits (Figure 6). Spot-like PrPd deposition was observed in
areas with β-3-tubulin staining (Figure 6A). In some cases,
PrPd colocalized with neuronal lysosomes (Figure 6A, insets).
Purkinje cells were surrounded by cells with intense PrPd
staining, while Purkinje cell bodies showed no or only very
faint staining for PrPd (Figure 6B; Supplementary Figure 2).
Interestingly, PrPd deposition was found extracellularly between
Purkinje cells in close vicinity (Supplementary Figure 2).
Surrounding cells stained positive for glial fibrillar acidic
protein (GFAP), suggesting that they represent Bergmann glia
(Figure 6C). Here, PrPd at least partially colocalized with
lamp-1, indicative of lysosomal localization of PrPd within
astrocytes (Figure 6C, arrows). PrPd deposition in astrocytes
has been reported previously for 22L infected C57BL/6 mice
(Diedrich et al., 1991). PrPd staining was also associated with
microglia (Figure 6D). In some instances, degenerated nuclei
were identified in iba-1 positive microglia in the 22L infected
cerebellar slices (Figure 6D, arrowheads). In conclusion, in 22L
infected cerebellar slices from C57BL/6JRj mice, PrPd deposits as
spot-like or fibrillar structures in the neuropil and is associated
with astrocytes, microglia and neurons. In line with in vivo
studies (Moore et al., 2008; Sarasa et al., 2012), PrPd is not (or
only at very low levels) located in Purkinje cells.
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FIGURE 5 | Neuropathological changes in 22L infected cerebellar slices. Slices exposed to Mock or 22L brain homogenate were cultured for 9 weeks. PrPd
was detected following antigen denaturation using mAb 4H11 (green). (A) Neurons were stained with pAb anti-β-3-tubulin (red). (B) Purkinje cells were labeled with
mAb against calbindin (red). (C) PAb anti-GFAP was used to stain astrocytes (red). (D) Microglia were detected with pAb anti-iba-1 (red). Nuclei were counterstained
with Hoechst. Molecular and Purkinje cell layers of folia IX were imaged by confocal microscopy using the tile scanning function with identical imaging settings for each
sample group. Scale bar: 50µm.
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FIGURE 6 | Cellular localization of PrPd in cerebellar slices. 9 weeks p.i., Mock exposed or 22L infected slices were subjected to antigen denaturation and
immunofluorescence staining. Cells in the molecular layer of folium IX were analyzed by confocal microscopy using digital zoom with identical imaging
(Continued)
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FIGURE 6 | Continued
settings for each sample group. PrPd was detected with mAb 4H11 (green). (A) Neurons were stained for β-3-tubulin (red). The insets respresent magnifications of the
indicated region. (B) Purkinje cells were stained with mAb anti-calbindin (red). (C) Astrocytes were labeled with pAb anti-GFAP (red). Arrows mark co-localization of PrPd
with lamp-1 within astrocytes. (D) PAb anti-iba-1 was used to detect microglia (red). Arrowheads mark degenerated nuclei within microglia, arrows mark lysosomes.
Lysosomes were labeled with mAb anti-lamp-1 (purple) and nuclei were counterstained with Hoechst. Mock exposed slices served as controls. Scale bar: 5µm.
Anti-prion Compound Dextran Sulfate
Reduces Abnormal Prion Protein
Deposition
To further confirm that the PrP staining observed in prion
infected slices correlates with prion infection, we treated
prion infected and uninfected slices with a known anti-prion
compound and monitored PrPd staining. Previous studies have
demonstrated that anti-prion compounds can inhibit chronic
prion infections also in cerebellar slices (Falsig et al., 2012). DS-
500 is a sulfated polysaccharide that has been used extensively
as a glycosaminoglycan mimetic with anti-prion activity in vivo
and in cell cultures (Ehlers and Diringer, 1984; Caughey and
Raymond, 1993; Wolf et al., 2015). The presence of up to
10µg/ml DS-500 in the culture medium over a period of 5
weeks had no significant effect on the viability of brain slices
(Figure 7A). DS-500 was added to the slices either during
the infection period (Figure 7B) or 3 weeks p.i. (Figure 7G).
Treatment of slices with 10µg/ml DS-500 during the first week
of infection was sufficient to drastically reduce prion replication
(Figures 7C–F). Slices that were treated with 10µg/ml DS-500
during the first week of infection showed significantly reduced
levels of PrPSc as assessed by western blot (Figures 7C,D) and
PrPd detected by immunofluorescence staining of whole mount
slices (Figures 7E,F). DS-500 also significantly reduced PrPSc and
PrPd when added for up to 5.5 weeks to slices with ongoing prion
infection (Figures 7H–K). The fact that the reduction of PrPSc
correlated with the reduction of PrPd (Figure 7L) strongly argues
that our staining method indeed detects disease-associated PrP.
We further assessed if continuous DS-500 treatment of prion
infected slices could reduce astrocytosis. Intense astrocytosis was
detected in 22L infected slices 8.5 weeks p.i. to prions (Figure 7L).
By contrast, in slices with ongoing DS-500 treatment (10µg/ml),
GFAP staining was comparable to Mock exposed slices. In
summary, the antigen denaturation technique used here allows
detailed analysis of disease-associated prion protein deposition
and pathologic changes upon prion infection ex vivo.
DISCUSSION
Organotypic slices represent a suitable alternative to in vivo
experiments and allow the analysis of prion replication in a
complex cell environment within weeks post infection (Falsig
et al., 2012). A limitation of this model so far was that the cellular
and subcellular distribution of disease-associated PrP could not
be assessed. Here we report the development of an antigen
denaturation protocol suitable for the simultaneous detection
of abnormal prion protein deposition and cellular markers in
organotypic slices. The combination of a prion susceptible ex vivo
central nervous system model and the simultaneous detection
of disease-specific PrP and cellular markers opens the avenue
for detailed analysis of prion replication and new modes of
intervention.
We studied in detail the pathologic consequences of
infection of wildtype organotypic cerebellar slices with mouse-
adapted prion strain 22L that specifically targets the cerebellum
(Karapetyan et al., 2009). In cerebellar wildtype slices, prion
strain 22L induced characteristic neuropathological changes
approximately 8–9 weeks post exposure to prions. Interestingly,
no significant changes in propidium iodide uptake were
identified between infected and uninfected slices, arguing that
slices were still viable. PrPSc propagation was readily detected
by western blot as soon as 21 days post infection with 22L,
comparable to the infection period required for PrPSc detection
using slices from transgenic tga20 mice that show tenfold
overexpression of mouse PrP (Falsig et al., 2008). This finding
is in agreement with in vivo data that demonstrate that the
higher cerebellar PrPC expression in this mouse model does not
correlate with increased PrPSc accumulation (Fischer et al., 1996;
Karapetyan et al., 2009).
The 22L PrPd deposition pattern identified in ex vivo infected
C57BL/6 cerebellar slices closely resembled that of in vivo
infected cerebella, strongly arguing that the 22L strain-specific
cell tropism is retained ex vivo. PrPd deposition appeared
granular and was most prominent in molecular and Purkinje
cell layers. Purkinje cell bodies were usually negative for PrPd,
with no or only very faint PrPd signals detected. Although
not primary targets of prion replication (Kim et al., 1990b),
Purkinje cells appeared reduced in numbers and degenerated.
The reason for Purkinje cell degeneration is unclear but might
be due to extrinsic causes, such as loss of granule neurons or
dysfunction of glia. PrPd staining appeared sometimes confined
to extracellular spaces (Supplementary Figure 2). In some
instances, PrPd was found to colocalize with lysosomal marker
lamp-1 within neurons, GFAP-positive cells and microglia. As
microglia are non-permissive to prion infection (Priller et al.,
2006), the presence of PrPd in microglia might be due to uptake
of PrPd or infected cells undergoing cell death. Consistent with
pathologic changes associated with 22L replication in vivo (Kim
et al., 1990a,b; Williams et al., 1997), we observed a severely
diminished number of granule neurons in prion infected slices.
Furthermore, reactive astro- and microgliosis was a prominent
feature in areas with abundant PrPd deposition.
In this study we have also shown that the effect of anti-
prion drugs can be tested both during acute and chronic prion
infections. We have used DS-500, a sulfated polyanion with
known anti-prion activity (Ehlers and Diringer, 1984; Caughey
and Raymond, 1993; Wolf et al., 2015). The mode of action
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FIGURE 7 | Anti-prion compound DS-500 reduces abnormal prion protein deposition. (A) Viability of slices cultured in the presence or absence of different
concentrations of DS-500. Slices were cultured for 1 week, then 1–10µg/ml DS-500 were added for 5 weeks. Slices were subsequently stained for dead cells using
(Continued)
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FIGURE 7 | Continued
propidium iodide (PI). Slices treated with 5µM staurosporine served as positive controls. Samples were analyzed by epifluorescence microscopy using the tile
scanning function with identical imaging settings. Scale bar: 500µm. Statistical analysis was performed using One-way ANOVA with Tukey’s multiple comparisons
test. Asterisks indicate significant changes (n = 3; ****p < 0.0001; ns, not significant). (B) Experimental setup to study the effect of DS-500 on the establishment of a
22L prion infection in cerebellar slices. Cerebellar slices were pretreated with different concentrations of DS-500 for 1 h and exposed to inoculum in the presence of
DS-500 for 1 h. Slices were maintained in medium containing DS-500 for 1 week. Slices were kept in normal medium for up to 8 weeks p.i. (C) Cerebellar slices were
lysed at week 5 p.i. and lysates were proteinase K-digested. MAb 4H11 was used to analyze PK-resistant PrP (PrPSc ) by western blot. Actin was detected as a
loading control in –PK samples. Mock treated slices served as controls. For presentation purposes additional lanes were excised. (D) Statistical analysis of PrPSc
levels detected by western blot. Bars represent mean values ± SD (n = 5). Statistical analysis was performed using One-way ANOVA with Dunnett’s multiple
comparisons test. Asterisks indicate significant changes in the mean values of DS-500 treated samples relative to control samples set to 100% (*p < 0.05; ns, not
significant). (E) Specific detection of PrPd following antigen denaturation (green). Samples were analyzed by epifluorescence microscopy using the tile scanning
function with identical imaging settings. Scale bar: 500µm. (F) PrPd intensity of 22L infected slices treated with 10µg/ml DS-500 was quantified relative to 22L
infected control slices set to 100%. Bars represent mean values ± SD (n = 4). Statistical analysis was performed using unpaired two-tailed t-test (**p < 0.01; ns, not
significant). (G) Experimental setup to study the effect of DS-500 on persistent 22L prion infection in cerebellar slices. After exposure to inoculum for 1 h, slices were
cultured with normal medium for 3 weeks. Subsequently, slices were cultured in the presence of DS-500 until 5 and 8.5 weeks p.i. (H) PK-resistant PrP (PrPSc )
present in slices 5 weeks p.i. was detected by western blot using mAb 4H11. Actin was detected in -PK samples as loading control. For presentation purposes
additional lanes were excised. No statistically significant changes in actin levels were observed between infected and uninfected slices (data not shown). (I)
Quantitative comparison of PrPSc levels in prion-infected control slices and DS-500 treated, infected slices. The amount of PrPSc in the 22L infected control slices was
set to 100% and was compared to the amount of PrPSc in the DS-500 treated, infected slices. Bars represent mean values ± SD (n = 3; *p < 0.05; ns, not significant).
(J) Detection of PrPd 8.5 weeks p.i. following antigen denaturation. Samples were analyzed by epifluorescence microscopy using tile scanning function with identical
imaging settings. Scale bar: 500µm. Shown are prion infected and Mock exposed slices that were/were not treated with 10µg/ml DS-500 for 5.5 weeks. The boxed
region was chosen for confocal microscopy analysis in (L). (K) PrPd intensity of 22L infected slices treated with 10µg/ml DS-500 for 5.5 weeks was quantified relative
to 22L infected control slices set to 100%. Bars represent mean values ± SD (n > 4, ****p < 0.0001). (L) Molecular and Purkinje cell layers of folia VII (boxed area in J)
were imaged by confocal microscopy using the tile scanning function with identical imaging settings for each sample group. PAb anti-GFAP was used to stain
astrocytes (red). PrPd was detected with mAb 4H11 (green). Nuclei were counterstained with Hoechst. Scale bar: 50µm. WB, western blot; IF, immunofluorescence.
of DS-500 and other glycosaminoglycan mimetics is complex
and likely involves direct effects on PrPSc synthesis and on
PrPSc stabilization. DS-500 has limited ability to cross the
blood brain barrier and thus likely impairs peripheral prion
replication (Koster et al., 2003). The experiments presented
here demonstrate that DS-500 also exhibits potent anti-prion
activity in the central nervous system. How exactly DS-500
impairs prion replication is unknown. Our recent study in several
cell culture models argues, that prion entry into target cells is
not impaired by DS-500 (Wolf et al., 2015). It is thus likely
that DS-500 counteracts prion infection downstream of prion
uptake.
Many pharmaceuticals are incapable of crossing the
blood brain barrier (Pardridge, 2012). While their use as
therapeutics for prion diseases is limited, testing the anti-prion
efficacy of drugs with known targets in organotypic brain
slices will help to understand the molecular mechanisms
underlying prion propagation in the central nervous
system.
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